PF-07055480 / Giroctocogene Fitelparvovec
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-07055480 / Giroctocogene Fitelparvovec, covering 2025-08-17 to 2025-08-17. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults [Phase 3]